<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Case report** **Açıklama:** 1. **Neonatal carbapenem infections:** Makalenin ana konusu &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/case-report-aciklama-1-neonatal-carbapenem-infections-makalenin-ana-konusu/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 22 Jan 2026 16:43:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Case report** **Açıklama:** 1. **Neonatal carbapenem infections:** Makalenin ana konusu &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Novel Triple Therapy for Neonatal Carbapenem Infections</title>
		<link>https://bioengineer.org/novel-triple-therapy-for-neonatal-carbapenem-infections/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 22 Jan 2026 16:43:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antibiotic resistance]]></category>
		<category><![CDATA[Carbapenem-Resistant Enterobacteriaceae]]></category>
		<category><![CDATA[Carbapenemase-producing Enterobacteriaceae]]></category>
		<category><![CDATA[Case Report** * **Neonatal Infections:** Makalenin ana odağı yenidoğanlardaki enfeksiyonlar. * **Carbapenem-Resistant Enterobacteriaceae (CRE):** Tedavi edilen spesifik ve tehlikeli bakteri]]></category>
		<category><![CDATA[Case report** **Açıklama:** 1. **Neonatal carbapenem infections:** Makalenin ana konusu]]></category>
		<category><![CDATA[combination therapy]]></category>
		<category><![CDATA[İçeriğe uygun 5 etiket: **Neonatal carbapenem infections]]></category>
		<category><![CDATA[İçerik analizine dayanarak en uygun 5 etiket: **Neonatal Infections]]></category>
		<category><![CDATA[triple combination therapy]]></category>
		<category><![CDATA[yenidoğanlarda görülen karbapenem dirençli enfeksiyonlar. 2. **Triple combination therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/novel-triple-therapy-for-neonatal-carbapenem-infections/</guid>

					<description><![CDATA[In recent years, the rise of multidrug-resistant bacteria has become a pressing concern in the realm of pediatric medicine. Among these, carbapenemase-producing Enterobacteriaceae (CPE) poses a significant risk, particularly for vulnerable populations such as neonates. In a groundbreaking case report, researchers Wang and Tan delve into the complex treatment options available for this challenging class [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319366</post-id>	</item>
	</channel>
</rss>
